**Human Health Project 1st July 2022 TO 30th June 2023** 

GROUP NAME: REPORTING PERIOD: GROUPS REFERENCE NUMBER: 

## **STATEMENT OF RECEIPTS AND PAYMENTS** 

|**Year to**<br>**Unrestricted**<br>**Restricted**<br>**Jun-23**<br>**Funds**<br>**Funds**<br>**TOTAL**<br>**£**<br>**£**<br>**£**<br>**Receipts:**<br>Halifax Foundation NI grant<br>0<br>-<br>**-**<br>Awards for All<br>-<br>**-**<br>Fundraising Appeals<br>-<br>0<br>**-**<br>Bank Interest<br>-<br>0<br>**-**<br>Generated Income<br>-<br>0<br>**-**<br>**Total Receipts**<br>**-**<br>**-**<br>**-**<br>**Payments:**<br>Accounting<br>-<br>0<br>**-**<br>Bank Fee<br>-<br>33<br>**33**<br>Dues & subs<br>0<br>**-**<br>Insurance<br>0<br>0<br>**0**<br>Programme expenses<br>0<br>0<br>**0**<br>Postage<br>-<br>0<br>**-**<br>Volunteer Cost<br>-<br>0<br>**-**<br>**Asset and investment purchase**<br>Purchase of Equipment<br>0<br>0<br>**0**<br>**Total Payments:**<br>**-**<br>**33**<br>**33**<br>**Net receipts/(payments)**<br>0<br>(33)<br>(33)<br>**Transfers to/(from) funds**<br>0<br>(1,270)<br>**(1,270)**<br>**Surplus/(deficit) for the year**<br>0<br>(1,303)<br>**(1,303)**<br>**Reconciliation 30.06.2023**<br>Cash at bank & in hand 30.06.2022<br>0<br>1,580<br>**14,125**<br>Surplus/(deficit) for this year end<br>0<br>(1,303)<br>**(1,303)**<br>Cash at bank & in hand 30.06.2023<br>**0**<br>**277**<br>**277**|**Period to**<br>**Jun-22**<br>**TOTAL**<br>**£**<br>-<br>-<br>-<br>-<br>**-**<br>501<br>32<br>13<br>1,470<br>11,679<br>-<br>-<br>0<br>**13,695**<br>(13,695)<br>1,150<br>(12,545)<br>14,125<br>(12,545)<br>**1,580**|
|---|---|



1 



**Human Health Project 1st July 2022 TO 30th June 2023 0** 

GROUP NAME: REPORTING PERIOD: GROUPS REFERENCE NUMBER: 

|GROUPS REFERENCE NUMBER:<br>**0**|GROUPS REFERENCE NUMBER:<br>**0**|
|---|---|
|**STATEMENT OF ASSET AND LIABILITIES**<br>Unrestricted<br>Restricted<br>**Total**<br>Total<br>**Funds Reconciliation**<br>Funds<br>Funds<br>**2023**<br>2022<br>£<br>£<br>**£**<br>£<br>Cash at bank & in hand 30.06.2022<br>0<br>1,580<br>**1,580**<br>14,125<br>Surplus/(deficit) for this year end<br>0<br>(1,303)<br>**(1,303)**<br>(12,545)||
|**Cash at bank & in hand 30.06.2023**|**0**<br>**277**<br>**277**<br>1,580|
|**Bank & Cash Balances**<br>Bank Deposit Accounts<br>Bank Current Accounts<br>Cash in Hand|Unrestricted<br>Restricted<br>**Total**<br>Total<br>Funds<br>Funds<br>**2023**<br>2022<br>£<br>£<br>£<br>£<br>0<br>0<br>0<br>0<br>-<br>277<br>**277**<br>1,580<br>-<br>0<br>**-**<br>-|
||-<br>277<br>**277**<br>1,580|
|**Other Assets**<br>Computer equipment. Inc Ipads|Unrestricted<br>Restricted<br>**Total**<br>Total<br>Funds<br>Funds<br>**2023**<br>2022<br>£<br>£<br>£<br>£<br>0<br>0<br>**0**<br>0|
||0<br>0<br>**0**<br>0|
|**Liabilities**<br>Accounts Payable<br>Owed to Funder|Unrestricted<br>Restricted<br>**Total**<br>Total<br>Funds<br>Funds<br>**2023**<br>2022<br>£<br>£<br>£<br>£<br>0<br>273<br>**273**<br>1,543<br>0<br>100<br>**100**<br>100|
||**0**<br>373<br>373<br>1,643|



The financial statements were approved by the Trustees on 26 January 2024 and were signed on their behalf by: 

|Chief Executive:|Date<br>23 February2024|
|---|---|



2 

